Supernus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 8.74 M | $434.17 M | 0.43% | 15.49% |
| VANGUARD GROUP INC | 01/29/2026 | 6.05 M | $300.61 M | 0.06% | 10.73% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 2.76 M | $137.37 M | -2.54% | 4.90% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 2.71 M | $134.80 M | -9.65% | 4.81% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 2.64 M | $131.21 M | 662.38% | 4.68% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 2.31 M | $114.69 M | 100.00% | 4.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 2.26 M | $112.56 M | 28.57% | 4.02% |
| STATE STREET CORP | 02/13/2026 | 2.22 M | $110.30 M | 1.45% | 3.94% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.73 M | $86.11 M | -0.47% | 3.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.47 M | $73.21 M | 4.46% | 2.61% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 1.45 M | $72.01 M | 12.67% | 2.57% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 02/05/2026 | 1.41 M | $69.90 M | 4.54% | 2.49% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 1.08 M | $53.71 M | 0.02% | 1.92% |
| MORGAN STANLEY | 02/13/2026 | 1.08 M | $53.65 M | 42.92% | 1.91% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 707.98 K | $35.19 M | -27.73% | 1.26% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 703.63 K | $34.97 M | -3.94% | 1.25% |
| NORTHERN TRUST CORP | 02/17/2026 | 670.41 K | $33.32 M | -4.71% | 1.19% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 660.31 K | $32.82 M | -43.23% | 1.17% |
| ASHFORD CAPITAL MANAGEMENT INC | 02/17/2026 | 612.54 K | $30.44 M | 8.66% | 1.09% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 553.10 K | $27.49 M | 46.68% | 0.98% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 526.22 K | $26.15 M | -6.00% | 0.93% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 520.75 K | $25.88 M | -38.22% | 0.92% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 483.40 K | $24.76 M | -5.02% | 0.86% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 467.89 K | $23.25 M | -1.72% | 0.83% |
| CITADEL ADVISORS LLC | 02/17/2026 | 452.96 K | $22.51 M | -68.03% | 0.80% |
| INVESCO LTD. | 02/19/2026 | 395.76 K | $19.67 M | 9.37% | 0.70% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 370.79 K | $18.43 M | -1.54% | 0.66% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 326.04 K | $16.20 M | 7.46% | 0.58% |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 02/18/2026 | 313.50 K | $15.58 M | -13.75% | 0.56% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 311.84 K | $15.50 M | 151.23% | 0.55% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 306.67 K | $15.23 M | 36.82% | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 02/09/2026 | 304.23 K | $15.12 M | 4.09% | 0.54% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 303.72 K | $15.09 M | 842.40% | 0.54% |
| ABRDN PLC | 01/16/2026 | 271.57 K | $13.50 M | 100.00% | 0.48% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 257.47 K | $12.80 M | -10.32% | 0.46% |
| JPMORGAN CHASE & CO | 02/11/2026 | 251.76 K | $12.51 M | 46.98% | 0.45% |
| GLENMEDE TRUST CO NA | 02/17/2026 | 239.18 K | $11.89 M | 100.00% | 0.42% |
| ARISTOTLE CAPITAL BOSTON, LLC | 02/17/2026 | 234.50 K | $11.65 M | -23.18% | 0.42% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 229.13 K | $11.39 M | 100.00% | 0.41% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 02/13/2026 | 198.41 K | $9.86 M | -9.27% | 0.35% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 197.74 K | $9.83 M | 385.07% | 0.35% |
| FREESTONE GROVE PARTNERS LP | 02/17/2026 | 196.32 K | $9.76 M | 100.00% | 0.35% |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 02/10/2026 | 193.57 K | $9.62 M | -2.85% | 0.34% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 189.94 K | $9.48 M | 100.00% | 0.34% |
| THIRD AVENUE MANAGEMENT LLC | 02/12/2026 | 189.49 K | $9.42 M | 0.00% | 0.34% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 183.69 K | $9.13 M | -18.87% | 0.33% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 181.03 K | $9.00 M | -1.25% | 0.32% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 165.22 K | $8.21 M | -67.56% | 0.29% |
| RHUMBLINE ADVISERS | 02/13/2026 | 164.35 K | $8.17 M | -3.21% | 0.29% |
| SEI INVESTMENTS CO | 02/13/2026 | 154.61 K | $7.68 M | 0.75% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Supernus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 483 institutional investors and hedge funds held shares of Supernus Pharmaceuticals Inc. The most heavily invested institutionals were:
Stephens Investment Management Group LLC: 1.35 M
Assenagon Asset Management S.A.: 530,618
Pictet Asset Management Holding SA: 450,764
SG Americas Securities, LLC: 377,213
Bank of New York Mellon Corp: 362,408
PRINCIPAL FINANCIAL GROUP INC: 341,117
101.27% of Supernus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 82.28 M shares in the last 24 months. This purchase volume represents approximately $4.46 B in transactions.